VPVy Pham

Vy Pham

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Vy Pham has a total of 56 co-authors. Here are the top co-authors by number of shared publications:

  • Betelihem B. Tobo

    Community Health Administration, DC Health, Washington, DC, USA

    4 shared publications
  • Eric Adjei Boakye

    St. Louis University Center for Health Outcomes Research (SLUCOR), Saint Louis, MO

    4 shared publications
  • Nosayaba Osazuwa-Peters

    Department of Head and Neck Surgery & Communication Sciences, Duke University School of Medicine, Durham, North Carolina, USA

    3 shared publications
  • Christine M. Markham

    Department of Health Promotion and Behavioral Sciences School of Public Health, University of Texas Health Science Center at Houston Houston Texas

    2 shared publications
  • Leping Wan

    Department of Radiation Oncology, Washington University School of Medicine, St. Louis, MO, USA

    2 shared publications
  • Lu-Yu Hwang

    Department of Epidemiology, School of Public Health, The University of Texas Health Science Center at Houston, Houston, TX 77030, USA

    2 shared publications

Latest Publications

  • Open Access

    Non-genetic risk factors associated with glenohumeral osteoarthritis-related shoulder arthroplasty

    by Abigail G. Carey-Ewend, Xiaoyi Xu, Vy Pham, Jay D. Keener, Elizabeth L. Yanik

  • Open Access

    Smartphone-Based Ecological Momentary Assessment as the New Standard Measure for Post-Stroke Functioning (Preprint)

    by Quoc Bui, Katherine J. Kaufman, Vy Pham, Eric J. Lenze, Jin-Moo Lee, David C. Mohr, Mandy W.M. Fong, Christopher L. Metts, Stephanie E. Tomazin, Alex W.K. Wong

    BACKGROUND Functional disability is common after stroke. To inform new treatments, better measures are needed to advance our understanding of post-stroke functioning. Ecological momentary assessment (EMA) provides a putatively valid measure of everyday functioning by assessing patients during their lived experiences. OBJECTIVE This study aims to validate the smartphone-based EMA to characterize post-stroke everyday functioning and symptoms. METHODS Participants (N=212) with mild to moderate stroke were assessed five times daily for 14 days with EMA surveys to appraise mental, somatic, and cognitive symptoms, and what, with whom, and where participants were doing activities. Participants also completed standardized assessments during lab visits. RESULTS Most participants (median age = 60 years) were ischemic stroke (90%) and neurologically mild (median NIHSS = 2). Total 14,140 EMA surveys were analyzed. Participants were home 78% of the time and primarily participated in passive, unproductive activities, especially watching television and resting. EMA was sensitive to indicators of post-stroke disability; unemployed participants reported fewer vocational activities (W =12183.5, P < .001) but more activities of daily living (ADL) (W =6995, P < .001) and passive activities (W =7499.5, P =.003) than employed counterparts. Users of mobility devices and participants with cognitive problems spent significantly less time on vocational activities (W =2717, P< .0001 for mobility devices; W =7278, P= .03 for cognitive problems) and more on ADL (W =4807.5, P= .010 for mobility devices; W =9516.5, P< .001 for cognitive problems) than non-users and those without cognitive problems. Our data supported the validity of EMA methods in stroke, with small-to-moderate correlations of EMA with in-lab measures of daily functioning and very large correlations between EMA and in-lab measures of symptoms, especially those measuring the same constructs. CONCLUSIONS Our findings reveal that EMA tracked post-stroke functioning precisely. EMA may be beneficial in examining post-stroke functional recovery, monitoring patients for home-based interventions, and for longitudinal research. CLINICALTRIAL NA

  • Disparities in human papillomavirus (HPV) vaccine initiation and completion based on sexual orientation among women in the United States

    by Eric Adjei Boakye, Nosayaba Osazuwa-Peters, Julia López, Vy T. Pham, Betelihem B. Tobo, Leping Wan, Mario Schootman, Jane A. McElroy

    We compared HPV vaccine initiation and completion of heterosexual with lesbian and bisexual (LB) women. We aggregated National Health and Nutrition Examination Survey data from 2009 to 2016 for 3,0...


  • Intravaginal practices and genital human papillomavirus infection among female sex workers in Cambodia

    by Thanh Cong Bui, Michael E. Scheurer, Vy Thi‐Tuong Pham, Ly Thi‐Hai Tran, Leng Bun Hor, Damon J. Vidrine, Michael W. Ross, Christine M. Markham

    Objectives: Intravaginal practices (IVPs) include washing, wiping, or inserting something inside the vagina. This study investigates the associations between IVPs and genital human papillomavirus (HPV) infection.Methods: We conducted a cross‐sectional study of 200 female sex workers aged 18 to 35 years in Phnom Penh, Cambodia. From August to September 2014. Data on sociodemographic characteristics, IVPs, and other behaviors were collected through face‐to‐face interviews. Self‐collected cervicovaginal specimens were tested for 37 HPV genotypes.Results: Multivariable Poisson regression models showed that a lower number of infecting HPV genotypes were associated with intravaginal washing in the past 3 months (incident rate ratios [IRR] = 0.65, 95% confidence interval [CI]: 0.46‐0.94) and often performing intravaginal washing shortly after sex (IRR = 0.89, 95% CI: 0.81–0.99). Intravaginal washing before vaginal sex, intravaginal wiping, and intravaginal insertion were not associated with HPV infection.Conclusion: These findings challenge the existing view that all types of vaginal cleansing are harmful. Specifically, intravaginal washing shortly after sex (mainly with water) may help prevent HPV infection in female sex workers, who have several partners and thus frequently expose to sources of HPV infection with different genotypes.


  • Abstract C58: Effect of physicians' recommendation on the perceived effectiveness of the HPV vaccine in preventing cervical cancer

    by Eric Adjei Boakye, Nosayaba Osazuwa-Peters, Vy Pham, Betelihem B. Tobo, Matthew C. Simpson, Thomas Burroughs, Paula Buchanan

    Background: The human papillomavirus (HPV) is the most common sexually transmitted infection in the United States, with nearly 80 million people currently infected. It causes virtually all cervical cancers in the United States. There are three prophylactic HPV vaccines approved and recommended in the United States, and they protect against 70-90% of the HPV types that cause cervical cancer. Although the HPV vaccine is safe and effective, vaccination rates remain suboptimal. Physicians' recommendation of the HPV vaccine is known to be the most important predictor of vaccine uptake, and prior research suggests that promoting the HPV vaccine as an anticancer vaccine increases vaccination rates. However, no previous national study has evaluated how physicians' recommendation of the HPV vaccine might influence patients' or parental views of the vaccines' effectiveness. We sought to assess how physicians' recommendation of the HPV vaccine influenced patients' view of the effectiveness of the vaccine in preventing cervical cancer. Methods: Nationally representative data (n=1171) on respondents who were or had immediate family between the ages of 9 and 27 years old were obtained from the 2014 Health Information National Trends Survey 4, Cycle 4. Outcome of interest was an “effective” response to the question: “In your opinion, how successful is the HPV vaccine at preventing cervical cancer?” Main independent variable was physician HPV vaccine recommendation in the last 12 months (yes, no, don't know). Weighted, multivariable logistic regression was used to evaluate the effect of physicians' recommendation of the HPV vaccine on patients' perception on the effectiveness of the vaccine in preventing cervical cancer. Results: Approximately 26% of respondents reported receiving a physician recommendation for the HPV vaccine and 28% perceived the vaccine as effective in preventing cervical cancer. Respondents who did not have a physician's HPV recommendation, or did not know they had one in the last 12 months were 55% (aOR = 0.45, 95% CI, 0.27 - 0.73) and 76% (aOR = 0.24, 95% CI, 0.12 - 0.48) less likely to perceive the HPV vaccine as effective against cervical cancer, respectively. Respondents were less likely to perceive the HPV vaccine as effective in preventing cervical cancer if they were aged 35-49 (aOR = 0.46, 95% CI, 0.25 - 0.82) vs. 18-34 and had a high school diploma (aOR = 0.44, 95% CI, 0.24 - 0.81) or some college education (aOR = 0.39, 95% CI, 0.23 - 0.66) compared with college degree. Conclusions: Only one in four respondents with an immediate family member eligible for the HPV vaccine received a physician recommendation in our study. However, those who received a recommendation were significantly more likely to perceive the HPV vaccine as effective in preventing cervical cancer. Our finding provides added impetus for more physicians to utilize every clinical encounter as an opportunity to recommend the HPV vaccine to age-eligible parents and patients. Citation Format: Eric Adjei Boakye, Nosayaba Osazuwa-Peters, Vy Pham, Betelihem B. Tobo, Matthew C. Simpson, Thomas Burroughs, Paula Buchanan. Effect of physicians' recommendation on the perceived effectiveness of the HPV vaccine in preventing cervical cancer [abstract]. In: Proceedings of the Tenth AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; 2017 Sep 25-28; Atlanta, GA. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2018;27(7 Suppl):Abstract nr C58.

  • Abstract 4255: Differences in the sociodemographic correlates of HPV-associated cancer survival in the United States

    by Nosayaba Osazuwa-Peters, Matthew C. Simpson, Eric Adjei Boakye, Kahee A. Mohammed, Longwen Zhao, Sai D. Challapalli, Rebecca L. Rohde, Vy T. Pham, Sean T. Massa, Mark A. Varvares

    Purpose: Human papillomavirus (HPV) is the most common sexually transmitted infection in the United States. One in every four individuals-nearly 80 million-is infected. More than 38,000 new cases of HPV-associated cancers are diagnosed annually. However, factors related to HPV-associated cancer survivorship, based on primary anatomic site, remain understudied. The aim of this study was to assess sociodemographic factors related to survival following diagnosis of HPV-associated cancers in the United States. Methods: Patients ≥18 years diagnosed with first-primary HPV-associated cancer between 2007 and 2014 were identified from the Surveillance, Epidemiology, and End Results 18. HPV-associated cancers sites were defined as anal, cervical, oropharyngeal, penile, vaginal, and vulvar per the International Classification of Diseases for Oncology, third edition codes. Kaplan-Meier curves showing cancer-specific survival (CSS) from each HPV-associated cancer site stratified by sex with differences assessed by log-rank tests. Fine and Gray proportional hazards regression models for each HPV-associated site controlled for clinical covariates and estimated sociodemographic predictors of hazard of death from cancer. Results: A total of 63,329 patients with HPV-associated cancers were included in the analyses. The most common sites were cervix for females (58%) and oropharynx for males (78%). Overall 8-year survival at the end of follow-up was 56%. For males, anal cancer had the lowest CSS (62%) compared to oropharyngeal (69%) and penile (72%) cancer (pCitation Format: Nosayaba Osazuwa-Peters, Matthew C. Simpson, Eric Adjei Boakye, Kahee A. Mohammed, Longwen Zhao, Sai D. Challapalli, Rebecca L. Rohde, Vy T. Pham, Sean T. Massa, Mark A. Varvares. Differences in the sociodemographic correlates of HPV-associated cancer survival in the United States [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2018; 2018 Apr 14-18; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2018;78(13 Suppl):Abstract nr 4255.


  • Abstract 4221: Factors associated with HPV vaccination initiation and completion among 18-26 year olds in the United States

    by Eric Adjei Boakye, Betelihem B. Tobo, Daphne Lew, Meera Muthukrishnan, Vy T. Pham, Rebecca Rohde, Thomas Burroughs, Mark A. Varvares, Nosayaba Osazuwa-Peters

    Background The HPV vaccine prevents HPV-associated cancers and genital warts, which cause significant morbidity and mortality in the US. While the vaccine is targeted toward 11-12-year-old boys and girls, there is a catch-up vaccination range up to 26 years. However, vaccination rates are very low among eligible young adults, aged 18-26 years, and besides college-related studies, not a lot is known about factors associated with the HPV vaccine uptake in this population. The aim of this study was to assess sociodemographic factors associated with HPV vaccination uptake in a nationally representative sample of 18-26-year-old adults. Methods The National Health Interview Survey 2014-2015 was examined for young adults, aged 18-26 years (n = 7588). HPV vaccine initiation was defined as receipt of at least one dose of the vaccine and completion as receipt of the three doses. Sociodemographic factors included age, gender, race, marital status, education, health insurance, regular provider, number of doctor visits, and geographic region. Survey-weighted multivariable logistic regression models were used to examine the socio-demographic factors that were associated with HPV vaccine uptake. Results Approximately 27% of respondents had initiated the HPV vaccine and 16% had completed the HPV vaccine. After adjusting for covariates, compared to females, males were 81% less likely to initiate HPV vaccine [(adjusted odds ratio) 0.19; (95 % confidence interval) 0.16-0.23]. Other factors associated with HPV vaccine initiation included having health insurance (1.70; 1.32-2.18), visiting the doctor’s office 6+ times (1.86; 1.48-2.34) and 1-5 times (2.09; 1.56-2.81) vs. no doctor’s office within the last 12 months, and having no high school diploma (0.46; 0.32-0.64) and having high school diploma (0.40; 0.31-0.52) vs. college degree or higher. The same factors were associated with HPV vaccine completion; but, being black (0.60; 0.44-0.83) vs. white and having no usual place of care (0.74; 0.57-0.96) were also associated with lower odds of completing the vaccine series. Conclusions Our study shows that there are sociodemographic factors associated with HPV vaccine uptake among young adults in the United States, and males, individuals with a lower education, and those without adequate healthcare access are less likely to initiate and complete the HPV vaccination. Our findings suggest it is necessary to develop targeted interventions to promote HPV vaccination among those in the catch-up age range. Citation Format: Eric Adjei Boakye, Betelihem B. Tobo, Daphne Lew, Meera Muthukrishnan, Vy T. Pham, Rebecca Rohde, Thomas Burroughs, Mark A. Varvares, Nosayaba Osazuwa-Peters. Factors associated with HPV vaccination initiation and completion among 18-26 year olds in the United States [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2017; 2017 Apr 1-5; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2017;77(13 Suppl):Abstract nr 4221. doi:10.1158/1538-7445.AM2017-4221

  • Abstract B79: Disparities in HPV vaccine initiation and completion based on sexual orientation among women in the United States

    by Eric Adjei Boakye, Nosayaba Osazuwa-Peters, Leping Wan, Betelihem B. Tobo, Vy Pham, Mario Schootman, Jane A. McElroy

    Background: Human Papillomavirus (HPV) is associated with multiple cancers and remains the most common sexually transmitted infection in the United States. Each year, approximately seven million U.S. women are newly infected with HPV, and about 17,000 develop new HPV-associated cancers. Three HPV vaccines have been licensed for use in preventing 70% to 90% of HPV strains associated with cervical and other anogenital cancers. Although vaccination provides an opportunity for the primary prevention of HPV associated cancers, uptake of the vaccine has been slow. Sexual minority women (i.e. lesbians and bisexuals, referred to as LB in our study) are at increased risk of acquiring HPV and HPV associated cancers from both female and male sexual partners. However, there is a dearth of research investigating HPV vaccination among sexual minorities. Therefore, the aim of this project was to compare HPV vaccine initiation and completion between straight/heterosexual and lesbian/bisexual women. Methods: We aggregated National Health and Nutrition Examination Survey data from 2009-2014 for 2,305 women aged 18 to 34 years. The censored upper age reflects availability of the HPV vaccine, which began in 2006. HPV vaccine initiation was defined as self-reported receipt of at least one dose of the vaccine. HPV vaccine completion was defined as self-reported receipt of all three recommended doses. Self-reported sexual orientation was dichotomized as straight/heterosexual vs. LB. Weighted percentages and multivariable logistic regression models were used to examine differences in HPV vaccine initiation and completion between straight/heterosexual and LB women. Covariates in the adjusted model included age, race, marital status, education, and household income. Results: Approximately 11% of respondents identified themselves as LB women. Respondents had initiated the HPV vaccine (22% of heterosexuals vs. 32% of LB women, p=0.0039) significantly more than had completed (15% of heterosexuals vs. 22% of LB women, p=0.0109). After adjusting for covariates, compared to straight/heterosexual women, LB women were 59% more likely to initiate HPV vaccine (aOR=1.59, 95% CI: 1.05-2.42). A one year increase in age was associated with lower odds of initiating HPV vaccination (aOR=0.81, 95% CI: 0.78-0.85). Compared to non-Hispanic White women, Hispanic women were less likely to initiate HPV vaccine (aOR=0.63, 95% CI: 0.42-0.94), and so were women with high school degree or less compared to those with college degree or higher (aOR=0.27, 95% CI: 0.17-0.42). A similar pattern was observed for HPV vaccine completion. In the adjusted model, LB women were 78% more likely to complete the HPV vaccine compared to straight/heterosexual women (aOR=1.78, 95% CI: 1.07-2.96). The same sociodemographic characteristics associated with decreased likelihood of HPV initiation were also significantly associated with HPV completion. Conclusion: We found that LB women had higher odds of HPV vaccine initiation and completion compared with straight/heterosexual women, although for both groups the vaccine uptake falls well below the target. Our finding that younger age predicts uptake of this vaccine is particularly promising for the LB population, wherein numerous reports indicate barriers to cancer screening such as access to care and physician's lack of knowledge regarding risk of HPV among LB women. We found LB women more likely to initiate and complete the HPV vaccination protocol, so understanding the drivers of vaccine uptake in the LB population may inform for use among the straight/heterosexual population. Citation Format: Eric Adjei Boakye, Nosayaba Osazuwa-Peters, Leping Wan, Betelihem B. Tobo, Vy Pham, Mario Schootman, Jane A. McElroy. Disparities in HPV vaccine initiation and completion based on sexual orientation among women in the United States. [abstract]. In: Proceedings of the Ninth AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; 2016 Sep 25-28; Fort Lauderdale, FL. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2017;26(2 Suppl):Abstract nr B79.

  • Perception of primary male sexual partners’ characteristics and women’s history of sexually transmissible infections in Ho Chi Minh City, Vietnam

    by Ly T Tran, Thanh C Bui, Vy T Pham, Christine M Markham, Alan G Nyitray, Michael D Swartz, Loi T Tran, Lu-Yu Hwang

    Background: Evidence regarding whether male partners’ characteristics can influence women’s likelihood of getting sexually transmissible infections (STIs) is insufficient and inconsistent. Our study examined associations between women’s perception of primary male partners’ demographic and behavioural characteristics and women’s history of bacterial STI diagnoses among 126 women at risk for STIs in Ho Chi Minh City, Vietnam. Methods: All variables were obtained by women’s self-report. Due to the excess zeroes of the number of bacterial STI diagnoses for women, we used Zero-Inflated Poisson regression to examine associations of interest. Results: Among women who had one lifetime male partner (n = 49), the partner’s number of female sexual partners [prevalence ratio (PR) = 4.63, 95%CI = 1.44–14.88] and number of STI diagnoses (PR = 27.32, 95%CI = 1.56–477.70) were associated with the woman’s number of bacterial STI diagnoses, after adjusting for women’s education level. For women who had >1 lifetime male partner (n = 77), a greater number of women’s bacterial STI diagnoses was also associated with their partners’ STI history (PR = 9.12, 95% CI = 2.44–34.11). Conclusions: An increased risk for STIs in women was associated with both individual characteristics and their primary male partner’s behavioural risk factors. Therefore, primary male partners’ risk factors should be included in STI risk assessments, treatment and interventions for women.


  • Self-reported oral health, oral hygiene, and oral HPV infection in at-risk women in Ho Chi Minh City, Vietnam

    by Thanh Cong Bui, Ly Thi-Hai Tran, Christine M. Markham, Thuy Thi-Thu Huynh, Vy Thi-Tuong Pham, Quan Minh Tran, Ngoc Hieu Hoang, Lu-Yu Hwang, Erich Madison Sturgis